Consolidated Statements Of Cash Flows (USD $)	3 Months Ended
	Sep. 30, 2012	Sep. 30, 2011
Cash Flows from Operating Activities:
Net (loss)	$ (433,436)	$ (789,649)
Adjustments to reconcile net loss to cash provided by operating activities of continuing operations:
Income from discontinued operations	(190,960)	288,619
Depreciation and amortization	3,743	3,707
Compensation expense related to stock options	16,485	23,898
Loss of Ocular Telehealth Management, LLC	(1,192)	(699)
Change in operating assets and liabilities:
Accounts receivable, net	413,431	973,365
Inventory, net	(359,325)	(385,307)
Other current and long-term assets	28,612	(55,708)
Accounts payable and accrued expenses	(204,303)	194,162
Net cash (used in) operating activities from continuing operations	(726,945)	252,388
Net cash (used in) provided by operating activities from discontinued operations	455,942	(211,860)
Net cash (used in) operating activities	(271,003)	40,528
Cash Flows from Investing Activities:
Purchase of fixed assets	0	(4,172)
Net cash (used in) investing activities from continuing operations	0	(4,172)
Net cash (used in) investing activities from discontinued operations including proceeds from sale of vascular assets	(8,618)	(2,755)
Net cash (used in) investing activities	(8,618)	(6,927)
Cash Flows from Financing Activities:
Proceeds from related party note payable	0	134,488
Principal payments on long-term debt	0	(88,555)
Net cash used in financing activities from continuing operations	0	45,933
Effect of exchange rate changes on cash and cash equivalents	(60,643)	(122,803)
Net (decrease) increase in cash and cash equivalents	(340,264)	(43,269)
Cash and cash equivalents, beginning of period	890,623
Cash and cash equivalents, end of period	550,359	1,871,945
Supplemental Schedule of Cash Flow Information:
Interest paid	$ 0	$ 82,491